189 related articles for article (PubMed ID: 28569923)
1. Interplay between elevated cellular fibronectin and plasma fibrin clot properties in type 2 diabetes.
Konieczyńska M; Bryk AH; Malinowski KP; Draga K; Undas A
Thromb Haemost; 2017 Aug; 117(9):1671-1678. PubMed ID: 28569923
[TBL] [Abstract][Full Text] [Related]
2. Gender-specific alterations in fibrin structure function in type 2 diabetes: associations with cardiometabolic and vascular markers.
Alzahrani SH; Hess K; Price JF; Strachan M; Baxter PD; Cubbon R; Phoenix F; Gamlen T; Ariëns RA; Grant PJ; Ajjan RA
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2282-7. PubMed ID: 22996148
[TBL] [Abstract][Full Text] [Related]
3. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
Konieczynska M; Fil K; Bazanek M; Undas A
Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
[TBL] [Abstract][Full Text] [Related]
4. Fibrin clot properties and haemostatic function in men and women with type 1 diabetes.
Tehrani S; Jörneskog G; Ågren A; Lins PE; Wallén H; Antovic A
Thromb Haemost; 2015 Feb; 113(2):312-8. PubMed ID: 25318636
[TBL] [Abstract][Full Text] [Related]
5. Plasma Protein Oxidation as a Determinant of Impaired Fibrinolysis in Type 2 Diabetes.
Bryk AH; Konieczynska M; Rostoff P; Broniatowska E; Hohendorff J; Malecki MT; Undas A
Thromb Haemost; 2019 Feb; 119(2):213-222. PubMed ID: 30605917
[TBL] [Abstract][Full Text] [Related]
6. Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long-term follow-up study.
Bryk AH; Konieczyńska M; Polak M; Plicner D; Bochenek M; Undas A
Cardiovasc Diabetol; 2021 Feb; 20(1):47. PubMed ID: 33602240
[TBL] [Abstract][Full Text] [Related]
7. Altered fibrin clot structure/function in patients with antiphospholipid syndrome: association with thrombotic manifestation.
Celińska-Lowenhoff M; Iwaniec T; Padjas A; Musiał J; Undas A
Thromb Haemost; 2014 Aug; 112(2):287-96. PubMed ID: 24652596
[TBL] [Abstract][Full Text] [Related]
8. Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk.
Gajos G; Konieczynska M; Zalewski J; Undas A
Cardiovasc Diabetol; 2015 May; 14():44. PubMed ID: 25928628
[TBL] [Abstract][Full Text] [Related]
9. Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
Matusik PT; Matusik PS; Kornacewicz-Jach Z; Małecka B; Ząbek A; Undas A
Int J Cardiol; 2017 Sep; 243():244-250. PubMed ID: 28571619
[TBL] [Abstract][Full Text] [Related]
10. BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
Greenhalgh KA; Strachan MW; Alzahrani S; Baxter PD; Standeven KF; Storey RF; Ariens RA; Grant PJ; Price JF; Ajjan RA
Thromb Haemost; 2017 Jan; 117(2):295-302. PubMed ID: 27929198
[TBL] [Abstract][Full Text] [Related]
11. The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL; Larsen SB; Phoenix F; Kurdee Z; Grant PJ; Ajjan RA
Thromb Haemost; 2014 Dec; 112(6):1142-50. PubMed ID: 25187394
[TBL] [Abstract][Full Text] [Related]
12. Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation.
Gronostaj K; Richter P; Nowak W; Undas A
Thromb Res; 2013 Mar; 131(3):262-7. PubMed ID: 23273404
[TBL] [Abstract][Full Text] [Related]
13. Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.
Mrozinska S; Cieslik J; Broniatowska E; Malinowski KP; Undas A
J Thromb Haemost; 2019 Nov; 17(11):1912-1922. PubMed ID: 31323706
[TBL] [Abstract][Full Text] [Related]
14. Altered plasma fibrin clot properties in essential thrombocythemia.
Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
[TBL] [Abstract][Full Text] [Related]
15. Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus.
Soma P; Pretorius E
Cardiovasc Diabetol; 2015 Jul; 14():96. PubMed ID: 26228646
[TBL] [Abstract][Full Text] [Related]
16. Altered plasma fibrin clot properties are associated with in-stent thrombosis.
Undas A; Zalewski J; Krochin M; Siudak Z; Sadowski M; Pregowski J; Dudek D; Janion M; Witkowski A; Zmudka K
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):276-82. PubMed ID: 19910643
[TBL] [Abstract][Full Text] [Related]
17. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality.
Undas A; Kolarz M; Kopeć G; Tracz W
Nephrol Dial Transplant; 2008 Jun; 23(6):2010-5. PubMed ID: 18156458
[TBL] [Abstract][Full Text] [Related]
18. Polyhedrocytes in blood clots of type 2 diabetic patients with high cardiovascular risk: association with glycemia, oxidative stress and platelet activation.
Gajos G; Siniarski A; Natorska J; Ząbczyk M; Siudut J; Malinowski KP; Gołębiowska-Wiatrak R; Rostoff P; Undas A
Cardiovasc Diabetol; 2018 Nov; 17(1):146. PubMed ID: 30466424
[TBL] [Abstract][Full Text] [Related]
19. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
Kwasny-Krochin B; Gluszko P; Undas A
Thromb Res; 2010 Jul; 126(1):e11-6. PubMed ID: 20471669
[TBL] [Abstract][Full Text] [Related]
20. Plasma fibrin clot properties in atopic dermatitis: links between thrombosis and atopy.
Nastałek M; Wojas-Pelc A; Undas A
J Thromb Thrombolysis; 2010 Aug; 30(2):121-6. PubMed ID: 20419337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
